Johnson & Johnson agrees to pay about US$117 million to settle US states’ mesh probe


U.S. state attorneys general said on Thursday that Johnson & Johnson and its unit had agreed to pay nearly US$117 million to settle litigation over deceptive marketing of the company's transvaginal surgical mesh devices.

FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo

(Updated: )

Share this content


REUTERS: Johnson & Johnson has agreed to pay nearly US$117 million to resolve allegations that it deceptively marketed transvaginal surgical mesh devices, U.S. state attorneys general said on Thursday.

The settlement resolves a multistate investigation that found J&J violated consumer protection laws by misrepresenting the safety and effectiveness of its devices and failing to sufficiently disclose risks associated with their use, the attorneys general said.



Thousands of women have sued the company and its Ethicon unit alleging that they were injured by its pelvic mesh devices, which are used to treat bladder issues and pelvic organ prolapse, in which organs shift from their normal positions.

The settlement resolves claims with 41 states and the District of Columbia.

The deal does not cover lawsuits over J&J's mesh marketing by four states, California, West Virginia, Kentucky and Mississippi, which remain pending.

A trial in California's case concluded in September, though a decision has not yet been issued. The state of Washington settled a similar case in April for US$9.9 million.



J&J in a statement on Thursday said the settlement contains no admission of liability or misconduct on the part of Ethicon.

Earlier this year, the U.S. Food and Drug Administration ordered makers of all implants to immediately stop their sale and distribution amid claims that they caused pain, perforations, urinary problems, bleeding and Read More – Source

Related Posts